Bill > SF2959

This bill extends the prohibition on drug manufacturers interfering with access to 340B drugs by repealing the existing expiration clause in Minnesota Statutes. The 340B Drug Pricing Program is a federal program that allows certain healthcare providers (like hospitals serving low-income communities, community health centers, and some clinics) to purchase outpatient drugs at significantly reduced prices. By removing the July 1, 2027 expiration date from the current law, the bill effectively makes the prohibition on manufacturers' interference with 340B drug access permanent. This means drug manufacturers will continue to be restricted from taking actions that would impede healthcare providers' ability to access discounted drugs under the 340B program, which helps ensure that safety-net healthcare providers can continue to provide affordable medications to vulnerable populations.

Health and Social Services

https://www.revisor.mn.gov/bills/bill.php?b=Senate&f=SF2959&ssn=0&y=2025